A Phase 1, Dose-Escalation Study of Pixantrone Monotherapy in Pediatric Patients With Relapsed or Refractory Cancer
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2017
At a glance
- Drugs Pixantrone (Primary)
- Indications Cancer; Lymphoma; Solid tumours
- Focus Adverse reactions; Therapeutic Use
- Sponsors CTI BioPharma
- 14 Dec 2016 Status changed from not yet recruiting to recruiting.
- 13 Oct 2016 Planned initiation date changed from 1 Aug 2016 to 1 Oct 2016.
- 20 Jul 2016 Planned initiation date changed from 1 Jun 2016 to 1 Aug 2016.